Having trouble accessing articles? Reset your cache.

North American Vaccine: 4th strike

When its Certiva diphtheria, tetanus and acellular pertussis (DTaP) vaccine received FDA approval last year, North American Vaccine Inc. hoped that its marketing deal with Abbott Laboratories would allow the product to compete with the three already marketed DTaP vaccines.

But earlier this month, Abbott (Abbott Park, Ill.) terminated its

Read the full 504 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE